Loading clinical trials...

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT00593541

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software ca...

Lead sponsor: University of California, Davis•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1

A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers

NCT02910635 · Abnormalities, Cardiovascular

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 30, 2017Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment42

Start dateMay 1999

Last updatedMay 30, 2017

Condition

Abnormalities, Cardiovascular

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions